Answers are grounded in this paper and cite their sources.
Several alternatives and adjunct DED therapies are being investigated that target various aspects of disease. For many, more robust studies are required to assess their sustainability and applicability.
No takes yet. Share an insight, caveat, or question.
Mittal et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: